Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ALS LIMITED Board/Management Information 2023

Mar 12, 2023

64365_rns_2023-03-12_783e5e69-c9a1-497b-a4d8-b4768cf32f3d.pdf

Board/Management Information

Open in viewer

Opens in your device viewer

asx/media release

==> picture [61 x 78] intentionally omitted <==

13 March 2023

Appointment of Interim CEO

Further to the announcement made on 7 March 2023 ALS Limited (ASX Code: ALQ) provides details of the terms of employment of Mr Malcolm Deane in his capacity as Interim Chief Executive and Managing Director of ALS Limited.

A summary of the key terms of employment are attached.

Approved for release by the Company Secretary.

-ENDS-

For further information, please contact:

Cameron Sinclair Head of Investor Relations ALS Limited +61 412 430 393 [email protected]

About ALS Limited

ALS is a global Testing, Inspection & Certification business. The company’s strategy is to broaden its exposure into new sectors and geographies where it can take a leadership position.

alsglobal.com

Interim Chief Executive Officer & Managing Director: Summary of

Key Terms of Employment

ItemStart dateTerm ofappointment Details6 March 2023Interim position and no fixed term. Termination i n accordance withprovisions noted below.
Location Mr Deane will be based in Houston and travel to Australia as required toperform his duties.
FixedRemuneration US$650,000.00.
Short TermIncentive (STI) Up to 70% of fixed remuneration at the target level of performance and upto 100% of fixed remuneration at outperformance level.Payment of any STI is dependent on achievement of financial KPls (55%),Strategy KPIs (20%), ESG KPls (10%) and Organizational Capability KPIs(15%). One third of STI payments will be deferred into Share Rights that willvest in two years, and STI Payments achieved at the outperformance level willbe deferred into Share Rights for a period of two years, no dividends will bepaid during the two-year vesting period.Equity awards are subject to Shareholder approvals.Claw Back - No STI payments will apply for misrepresentation of financial andnon-financial KPI results. Material misstatements discovered after the STIpayment has been made may result in having to return the payment to theCompany.The terms and conditions of the STI Plan for future years are subject to thediscretion of the Board.
Long TermIncentive (LTI) Up to 110% of fixed remuneration, vesting is dependent on achievement ofthe EPS, TSR, ROCE and EBITDA performance hurdles, measured over a periodof three years.Equity awards are subject to Shareholder approvals.The terms and conditions of the LTI Plan for future years are subject to thediscretion of the Board.
SchoolAllowance An annual allowance of US$78,000 will continue to be paid to support thefamily education costs following relocation to the United States fromArgentina.
Notice & A period of 12 months notice must be given by either party for termination.
Termination Termination due to serious misconduct, may be made with no notice.
Termination as a result of retirement, death or serious illness subject to
Board discretion may result in pro-rated LTI vesting.
All accrued statutory leave entitlements will be paid out upon termination.
Confidentiality The interests of the Company are protected by provisions regarding intellectual
& Intellectual property and confidential information during and after the term of employment.
Property
Restraints A period of up to 12 months' post-employment restraint will apply.